Effects of Choroidal Vascular Hyperpermeability on Anti–Vascular Endothelial Growth Factor Treatment for Polypoidal Choroidal Vasculopathy

• Published in: American journal of ophthalmology Vol. 156; no. 6; pp. 1192 - 1200.e1
• Main Authors: Cho, Han Joo, Kim, Hyoung Seok, Jang, Young Seok, Han, Jung Il, Lew, Young Ju, Lee, Tae Gon, Kim, Chul Gu, Kim, Jong Woo
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.12.2013; Elsevier Limited
• Subjects: Aged; Angiogenesis Inhibitors - therapeutic use; Antibodies, Monoclonal, Humanized - therapeutic use; Bevacizumab; Capillary Permeability; Choroid - blood supply; Choroid Diseases - diagnosis; Choroid Diseases - drug therapy; Choroid Diseases - physiopathology; Colleges & universities; Coloring Agents; Diabetic retinopathy; Female; Fluorescein Angiography; Hemorrhage; Hospitals; Humans; Indocyanine Green; Intravitreal Injections; Macular degeneration; Male; Medical imaging; Myopia; Ophthalmology; Polyps - diagnosis; Polyps - drug therapy; Polyps - physiopathology; Ranibizumab; Retrospective Studies; Statistical analysis; Tomography; Tomography, Optical Coherence; University colleges; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity - physiology

To evaluate the effect of choroidal vascular hyperpermeability, as determined using indocyanine green angiography (ICGA), on the outcome of anti–vascular endothelial growth factor (VEGF) treatment for polypoidal choroidal vasculopathy (PCV). Retrospective comparative series. Based on the presence of...